Data / Drug companies / Losartan potassium and hydrochlorothiazide
Losartan potassium and hydrochlorothiazide: 31 companies and 111 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Losartan potassium and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 31 companies, with 111 products in commercial distribution. 108 of the products (97.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on May 27, 2026.
The request: Get every company that lists losartan potassium and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 31
- Products
- 111
- Generic (ANDA) products
- 108 (97.3%)
- Application numbers
- 11
- Routes
- Oral
- Brand names
- Hyzaar
- openFDA record search
- api.fda.gov
Companies that list losartan potassium and hydrochlorothiazide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 15 | tablet, film coated; tablet | Generic drugs (ANDA) | September 4, 2024 |
| Direct_Rx | 12 | tablet, film coated; tablet | Generic drugs (ANDA) | February 21, 2022 |
| Bryant Ranch Prepack | 8 | tablet, film coated; tablet | Generic drugs (ANDA) | February 15, 2018 |
| Proficient Rx LP | 7 | tablet, film coated | Generic drugs (ANDA) | May 23, 2016 |
| Bryant Ranch Prepack | 6 | tablet, film coated | Generic drugs (ANDA) | May 14, 2025 |
| Remedyrepack Inc. | 4 | tablet, film coated | Generic drugs (ANDA) | May 16, 2022 |
| Alembic Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 23, 2016 |
| Alembic Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | May 23, 2016 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | October 6, 2010 |
| AvKARE | 3 | tablet, film coated | Generic drugs (ANDA) | August 31, 2022 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 27, 2026 |
| Granules Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 29, 2023 |
| Jubilant Cadista Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | October 30, 2012 |
| Lupin Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | October 6, 2010 |
| Macleods Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | September 10, 2012 |
| NorthStar Rx LLC | 3 | tablet, film coated | Generic drugs (ANDA) | September 4, 2024 |
| Organon LLC | 3 | tablet, film coated | New drug applications (NDA) | June 1, 2021 |
| Preferred Pharmaceuticals Inc. | 3 | tablet, film coated; tablet | Generic drugs (ANDA) | April 15, 2024 |
| Solco Healthcare US, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | February 15, 2018 |
| Teva Pharmaceuticals USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | April 6, 2010 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 21, 2017 |
| Bryant Ranch Prepack | 2 | tablet, film coated | Generic drugs (ANDA) | October 30, 2012 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | May 23, 2016 |
| Proficient Rx LP | 2 | tablet, film coated | Generic drugs (ANDA) | February 15, 2018 |
| QPharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | February 15, 2018 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | July 21, 2017 |
| Coupler LLC | 1 | tablet, film coated | Generic drugs (ANDA) | December 2, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 30, 2012 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | October 6, 2010 |
| Quality Care Products, LLC | 1 | tablet, film coated | Generic drugs (ANDA) | August 28, 2024 |
| St. Mary's Medical Park Pharmacy | 1 | tablet, film coated | Generic drugs (ANDA) | September 30, 2022 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 103 | 92.8% |
| Tablet | 8 | 7.2% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 108 | 97.3% |
| New drug applications (NDA) | 3 | 2.7% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin 2 Receptor Blocker | 111 |
| Thiazide Diuretic | 111 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.